NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

Little bearing, especially if there is a buyout. Anyone around for Hospital Exemption in Germany knows that when NWBO brags about revenue generating activity it is best to get the whole salt shaker out.

TLD is the main concern, not what any competent management team should be doing just as part of running any business that manufactures anything. If we have to think it is a big deal for them to execute on something so basic then we’re in trouble. That’s why I say it’s a distraction and should not move the share price (though it might until management lets the SP wither on the vine again).